Dr. Reddy's launches generic epilepsy drug

Divalproex sodium extended-release tablets launched in 250-mg, 500-mg strengths

HYDERABAD, India — Indian drug maker Dr. Reddy's Labs has launched a generic treatment for epilepsy, the company said.

Dr. Reddy's announced the launch of divalproex sodium extended-release tablets in the 250-mg and 500-mg strengths, used to treat epileptic seizures. The 250-mg tablets are available in bottle count sizes of 100, while the 500-mg tablets are available in sizes of 100 and 500.

The drug is a generic version of AbbVie's Depakote ER. Branded and generic versions of the drug had sales of about $194 million during the 12-month period that ended in June, according to IMS Health.

Are you a nurse practitioner or physician's assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.

Login or Register to post a comment.